Prucalopride Versus Placebo in Gastroparesis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Controlled cross-over study of prucalopride 2 mg daily or placebo in gastroparesis (idiopathic or diabetic). Patients will be randomized to 4 week treatment with the first regimen (double-blind), followed by a 2-week washout and 4 week treatment with the second regimen in cross-over.
Epistemonikos ID: 0bf7d2e87308d529573f67d3e9689ee4e9323b81
First added on: May 12, 2024